Sung Lee Cytokinetics Inc (CYTK) insider trading activity

CYTK Quotes by TradingView

Sung Lee is EVP, Chief Financial Officer of CYTOKINETICS INC. Currently has a direct ownership of 74,442 shares of CYTK, which is worth approximately $3.22 Million. The most recent transaction as insider was on Mar 14, 2025, when has been sold 32,687 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.4K
98.77% 3M change
n/a 12M change
Total Value Held $3.22 Million

Sung Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2025
BUY
Grant, award, or other acquisition
-
32,687 Added 30.51%
74,442 Common Stock
Dec 03 2024
SELL
Payment of exercise price or tax liability
$79,119 $51.51 p/Share
1,536 Reduced 3.94%
37,451 Common Stock
Dec 03 2024
BUY
Grant, award, or other acquisition
-
8,607 Added 17.09%
41,755 Common Stock
May 31 2024
BUY
Grant, award, or other acquisition
-
34,684 Added 50.0%
34,684 Common Stock

Also insider at

SGMO
SANGAMO THERAPEUTICS, INC Healthcare
EVP, Chief Financial Officer
VIR
Vir Biotechnology, Inc. Healthcare
EVP & Chief Financial Officer
SL

Sung Lee

EVP, Chief Financial Officer
Brisbane, CA

Track Institutional and Insider Activities on CYTK

Follow CYTOKINETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

News

Receive news related to CYTOKINETICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYTK